{{cs1 config|name-list-style=vanc}} '''Amphetamine dependence''' refers to a state of psychological dependence on a drug in the amphetamine class.<ref>{{cite web |url=https://www.lecturio.com/concepts/amphetamine-use-disorder/|title=Amphetamine Use Disorder |website=The Lecturio Medical Concept Library |access-date=2021-06-23}}</ref><ref>{{cite web |url=https://www.drugabuse.gov/publications/drugfacts/methamphetamine|title=AWhat is methamphetamine?|website=National Institute on Drug Abuse |date=16 May 2019|access-date=2021-06-23}}</ref> Stimulants such as amphetamines and cocaine do not cause somatic symptoms upon cessation of use but rather neurological-based mental symptoms.<ref name="NHMH_3e-Physical dependence + psychostimulant addiction treatment2">{{cite book|title=Molecular Neuropharmacology: A Foundation for Clinical Neuroscience|vauthors=Malenka RC, Nestler EJ, Hyman SE, Holtzman DM|publisher=McGraw-Hill Medical|year=2015|isbn=978-0-07-182770-6|edition=3rd|location=New York|chapter=Chapter 16: Reinforcement and Addictive Disorders|quote=Pharmacologic treatment for psychostimulant addiction is generally unsatisfactory. As previously discussed, cessation of cocaine use and the use of other psychostimulants in dependent individuals does not produce a physical withdrawal syndrome but may produce dysphoria, anhedonia, and an intense desire to reinitiate drug use.}}</ref>{{Infobox medical condition (new) | name = Amphetamine dependence | synonyms = | image = Methamphetamine.svg | caption = The structural formula of methamphetamine | pronounce = | field = Toxicology, psychiatry | symptoms = | complications = | onset = | duration = | types = | causes = | risks = | diagnosis = | differential = | prevention = | treatment = | medication = | prognosis = | frequency = | deaths = }}
Signs of amphetamine intoxication manifest themselves in euphoria, hypersexuality, tachycardia, diaphoresis, and intensifications of the train of thought, speech, and movement. Over time, neurodegenerative changes become apparent in the form of altered behavior, reduced cognitive functions, and signs of neurological damage, such as a decrease in the levels of dopamine transporters (DAT) and serotonin transporters (SERT) in the brain.<ref name="pmid193282133">{{cite journal|vauthors=Krasnova IN, Cadet JL|date=May 2009|title=Methamphetamine toxicity and messengers of death|journal=Brain Res Rev|volume=60|issue=2|pages=379–407|doi=10.1016/j.brainresrev.2009.03.002|pmc=2731235|pmid=19328213|quote=Neuroimaging studies have revealed that METH can indeed cause neurodegenerative changes in the brains of human addicts (Aron and Paulus, 2007; Chang et al., 2007). These abnormalities include persistent decreases in the levels of dopamine transporters (DAT) in the orbitofrontal cortex, dorsolateral prefrontal cortex, and the caudate-putamen (McCann et al., 1998, 2008; Sekine et al., 2003; Volkow et al., 2001a, 2001c). The density of serotonin transporters (5-HTT) is also decreased in the midbrain, caudate, putamen, hypothalamus, thalamus, the orbitofrontal, temporal, and cingulate cortices of METH-dependent individuals (Sekine et al., 2006).}}</ref> Amphetamine use within teenagers can have lasting effects on their brain, in particular the prefrontal cortex. Amphetamine use is rising among students due to the ability to easily access prescribed stimulants like Adderall.<ref>{{Cite journal|last=Varga|first=Matthew D.|date=2012-06-06|title=Adderall Abuse on College Campuses: A Comprehensive Literature Review|journal=Journal of Evidence-Based Social Work|volume=9|issue=3|pages=293–313|doi=10.1080/15433714.2010.525402|issn=1543-3714|pmid=22694135|s2cid=23405226}}</ref> Also, in case of chronic use, vegetative disorders soon occur such as bouts of sweating, trouble sleeping, tremor, ataxia and diarrhea; the degradation of the personality takes place relatively slowly.<ref name=":12">J. Saarma "Kliiniline psühhiaatria". Tallinn, 1980, p. 139</ref><ref name=":22">{{cite web|last=O'Connor|first=Patrick|title=Amphetamines: Drug Use and Abuse|url=http://www.merckmanuals.com/home/special_subjects/drug_use_and_abuse/amphetamines.html|access-date=26 September 2013|work=Merck Manual Home Health Handbook|publisher=Merck}}</ref> Tolerance is expected to develop with regular substituted amphetamine use.<ref name=":22" /> When substituted amphetamines are used, drug tolerance develops rapidly.<ref name="Cochrane 20132">{{cite journal|last=Pérez-Mañá|first=C|author2=Castells X|author3=Torrens M|author4=Capellà D|author5=Farre M.|date=September 2013|title=Efficacy of psychostimulant drugs for amphetamine abuse or dependence|journal=Cochrane Database of Systematic Reviews|volume=2013|issue=9|article-number=CD009695|doi=10.1002/14651858.CD009695.pub2|pmid=23996457|doi-access=free|pmc=11521360}}</ref> Amphetamine dependence has shown to have the highest remission rate compared to cannabis, cocaine, and opioids.<ref>{{Cite journal|date=2010-08-01|title=Systematic review of prospective studies investigating "remission" from amphetamine, cannabis, cocaine or opioid dependence|url=https://www.sciencedirect.com/science/article/abs/pii/S0306460310000985|journal=Addictive Behaviors|language=en|volume=35|issue=8|pages=741–749|doi=10.1016/j.addbeh.2010.03.019|issn=0306-4603|last1=Calabria|first1=Bianca|last2=Degenhardt|first2=Louisa|last3=Briegleb|first3=Christina|last4=Vos|first4=Theo|last5=Hall|first5=Wayne|last6=Lynskey|first6=Michael|last7=Callaghan|first7=Bridget|last8=Rana|first8=Umer|last9=McLaren|first9=Jennifer|pmid=20444552|url-access=subscription}}</ref> Severe withdrawal associated with dependence from recreational substituted amphetamine use can be difficult for a user to cope with.<ref>[http://www.acnp.org/g4/GN401000166/CH162.htm#SSAT Chronic Amphetamine Use and Abuse] {{webarchive|url=https://web.archive.org/web/20100403085040/http://www.acnp.org/g4/GN401000166/CH162.htm#SSAT|date=April 3, 2010}}</ref><ref>{{cite journal|vauthors=Sax KW, Strakowski SM|year=2001|title=Behavioral sensitization in humans|journal=J Addict Dis|volume=20|issue=3|pages=55–65|doi=10.1300/J069v20n03_06|pmid=11681593|s2cid=1606101}}</ref><ref>{{cite journal|author1=I. Boileau|author2=A. Dagher|author3=M. Leyton|author4=R. N. Gunn|author5=G. B. Baker|author6=M. Diksic|author7=C. Benkelfat|year=2006|title=Modeling Sensitization to Stimulants in Humans: An <nowiki>[11C]</nowiki>Raclopride/Positron Emission Tomography Study in Healthy Men|journal=Arch Gen Psychiatry|volume=63|issue=12|pages=1386–1395|doi=10.1001/archpsyc.63.12.1386|pmid=17146013|doi-access=}}</ref> Long-term use of certain substituted amphetamines, particularly methamphetamine, can reduce dopamine activity in the brain.<ref name="Malenka3">{{cite book|title=Molecular Neuropharmacology: A Foundation for Clinical Neuroscience|vauthors=Malenka RC, Nestler EJ, Hyman SE|publisher=McGraw-Hill Medical|year=2009|isbn=978-0-07-148127-4|veditors=Sydor A, Brown RY|edition=2nd|location=New York|page=370|chapter=15|quote=Unlike cocaine and amphetamine, methamphetamine is directly toxic to midbrain dopamine neurons.}}</ref><ref name="pmid193282133" /> thumb|Adderall- Prescribed Amphetamine For amphetamine dependent individuals, psychotherapy is currently the best treatment option as no pharmacological treatment has been approved.<ref name="Cochrane 20132"/> Another treatment option for amphetamine dependence is aversion therapy based on classical conditioning module; this will combine the amphetamine with a negative thing or opposite stimulus.<ref>{{Cite web|title=Title Page – Abnormal Psychology|url=https://opentext.wsu.edu/abnormal-psych/front-matter/title-page/|access-date=2021-05-28|website=opentext.wsu.edu}}</ref> Treatment for amphetamines is growing at extremely high rates around the world.<ref>{{Cite journal|date=2018-11-01|title=Corrigendum to "Pharmacotherapy for amphetamine dependence: A systematic review" [Drug Alcohol Depend. 191 (2018) 309–337]|journal=Drug and Alcohol Dependence|language=en|volume=192|page=238|doi=10.1016/j.drugalcdep.2018.09.002|issn=0376-8716|doi-access=|last1=Lee|first1=Nicole K.|last2=Jenner|first2=Linda|last3=Harney|first3=Angela|last4=Cameron|first4=Jacqui|pmid=30278418|s2cid=52914625 }}</ref> Psychostimulants that increase dopamine and mimic the effects of substituted amphetamines, but with lower abuse liability, could theoretically be used as replacement therapy in amphetamine dependence.<ref name="Cochrane 20132" /> However, the few studies that used amphetamine, bupropion, methylphenidate, and modafinil as a replacement therapy did not result in less methamphetamine use or craving.<ref name="Cochrane 20132" />
==References== {{Reflist}}
== External links == {{Medical resources | DiseasesDB = | ICD10 = {{ICD10|F|15||f|10}}.0–.9 (amphetamine use disorders)<br />{{ICD10|F|15||f|10}}.2 (dependence syndrome)<br />{{ICD10|F|15||f|10}}.3 (withdrawal state) | ICD9 = {{ICD9|304.4}} | ICDO = | OMIM = | MedlinePlus = | eMedicineSubj = | eMedicineTopic = | MeshID = }} +{{Commons category-inline}}
{{Addiction|state=expanded}} {{methamphetamine}} {{Psychoactive substance use}}
{{DEFAULTSORT:Amphetamine Dependence}} Category:Methamphetamine and health Category:Amphetamine Category:Substance dependence